- Home
- ACIU vs SGC Comparison
ACIU vs SGC Comparison
Compare ACIU & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- SGC
- Stock Information
- Founded
- ACIU 2003
- SGC 1920
- Country
- ACIU Switzerland
- SGC United States
- Employees
- ACIU N/A
- SGC N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- SGC Apparel
- Sector
- ACIU Health Care
- SGC Consumer Discretionary
- Exchange
- ACIU Nasdaq
- SGC Nasdaq
- Market Cap
- ACIU 247.4M
- SGC 281.4M
- IPO Year
- ACIU 2016
- SGC N/A
- Fundamental
- Price
- ACIU $1.48
- SGC $10.23
- Analyst Decision
- ACIU Strong Buy
- SGC Strong Buy
- Analyst Count
- ACIU 2
- SGC 2
- Target Price
- ACIU $12.00
- SGC $19.00
- AVG Volume (30 Days)
- ACIU 192.5K
- SGC 67.2K
- Earning Date
- ACIU 05-12-2025
- SGC 05-06-2025
- Dividend Yield
- ACIU N/A
- SGC 5.47%
- EPS Growth
- ACIU N/A
- SGC 35.19
- EPS
- ACIU N/A
- SGC 0.73
- Revenue
- ACIU $30,136,397.00
- SGC $565,676,000.00
- Revenue This Year
- ACIU N/A
- SGC $4.67
- Revenue Next Year
- ACIU $676.94
- SGC $5.01
- P/E Ratio
- ACIU N/A
- SGC $14.01
- Revenue Growth
- ACIU 84.51
- SGC 4.12
- 52 Week Low
- ACIU $1.43
- SGC $9.11
- 52 Week High
- ACIU $4.98
- SGC $21.80
- Technical
- Relative Strength Index (RSI)
- ACIU 24.24
- SGC 38.49
- Support Level
- ACIU $1.48
- SGC $10.09
- Resistance Level
- ACIU $1.62
- SGC $10.71
- Average True Range (ATR)
- ACIU 0.12
- SGC 0.54
- MACD
- ACIU -0.00
- SGC 0.13
- Stochastic Oscillator
- ACIU 9.43
- SGC 54.63
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.